Cme Slides Forum

CME SLIDES FORUM

Archive 2006


	Impact of immunosuppressive agents on cardiovascular risk profile		The role of lipids and new onset diabetes mellitus
Prof F.P. Schena Head of the Nephrology, Dialysis and Transplant Unit of Bari University Bari, Italy		Prof J.M. Campistol Fac. of Medicine, Renal Transplantation Unit University Hospital Barcelona, Spain

	The contribution of CMV infection to cardiovascular complications after renal transplantation
Prof C. Legendre Necker Hospital Paris University V Paris, France


	Novel roles of the renal lymphatic system in health and disease		A genetic look at nephrolithiasis: therapeutic implications
Dr D. Kerjaschki Department of Pathology Medical University of Vienna Vienna, Austria		Dr G. Gambaro Nephrology Division, Ospedale Maggiore University of Verona Verona, Italy

	Therapeutic approaches to hyperphosphatemia in chronic renal failure
Prof T.B. Drueke Inserm U507 and Service de Nephrologie Hôpital Necker Paris, France


	Probing oxidant injury in the renal biopsy		New therapies for vasculitis using biologics
Dr M.P. Rastaldi Renal Immunopathology Laboratory Fondazione D’Amico per la Ricerca sulle Malattie Renali Milan, Italy		Dr W.L. Gross Dept. of Rheumatology – University of Schleswig-Holstein, Campus Lübeck Hospital of Internal Medicine and Clinical Immunology, Rheumaklinik Bad Bramstedt Lübeck, Germany

	Optimisation of maintenance treatments in ANCA-associated vasculitis
Dr L. Guillevin Hôpital Cochin University Paris - René Descartes Paris, France


	Cellular oxygen sensing in health and disease: from erythropoietin to oxygen		Inflammation and regression in nephroangiosclerosis
Prof P.J. Ratcliffe John Radcliffe Hospital Oxford University Oxford, United Kingdom		Dr C. Chatziantoniou Inserm U.702 Hopital Tenon Paris, France

	Regression of renal disease: what is the no-return point?
Prof G. Remuzzi Mario Negri Institute for Pharmacological Researches Negri Bergamo Laboratories Bergamo, Italy


	Mechanisms of vascular smooth muscle cell calcification		Genetic models and diseases of vascular calcification
Dr C.M. Shanahan Department of Cardiovascular Medicine University of Cambridge Cambridge, United Kingdom		Dr M. Ketteler Department of Nephrology University Hospital Aachen Aachen, Germany

	The bone and vascular connection
Prof J. Cannata-Andia Servicio de Metabolismo Oseo y Mineral Instituto “Reina Sofía” de Investigación, Hospital Central de Asturias Oviedo, Spain

Novel immunosuppressive regimens - an overview

Role of matrix metalloproteases in disease progression and repair: the two faces of the coin

Prof H. Ekberg
Dept of Transplant Surgery, Lund University
University Hospital
Malmoe, Sweden

Prof P. Ronco
INSERM Unit 702, University Pierre and Marie Curie
Tenon Hospital
Paris, France


	New insights into glomerular visceral and parietal epithelial cells derived from gene-manipulated animals		Protease-activated receptor-2 and renal fibrosis
Dr M. Moeller RWTH Aachen, Division of Nephrology Internal Medicine 2 Aachen, Germany		Dr L. Gesualdo S.C. di Nefrologia e Dialisi Azienda Ospedaliero-Universitaria 'OO.RR.' Foggia, Italy

	The intrarenal lymphatic system contributes to progressive damage
Dr D. Kerjaschki Department of Pathology Medical University of Vienna Vienna, Austria


	Coordinated regulation of renal calcium transport by vitamin D and dietary calcium		FGF-23: a new phosphate regulating hormone
Prof R. Bindels Department of Physiology Nijmegen Centre for Molecular Life Sciences Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands		Dr Y. Imanishi Department of Metabolism, Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine Osaka, Japan


	Coordinated regulation of renal calcium transport by vitamin D and dietary calcium		FGF-23: a new phosphate regulating hormone
Prof R. Bindels Department of Physiology Nijmegen Centre for Molecular Life Sciences Radboud University Nijmegen Medical Centre Nijmegen, The Netherlands		Dr Y. Imanishi Department of Metabolism, Endocrinology and Molecular Medicine Osaka City University Graduate School of Medicine Osaka, Japan


	Renal Behcet Disease		Etiologic factors in Balkan Endemic Nephropathy
Prof T. Akpolat Department of Nephrology Ondokuz Mayis University Samsun, Turkey		Dr D. Toncheva-Miteva Department of Medical Genetics Medical University of Sofia Sofia, Bulgaria


	Available methods of GFR determination: a critical assessment		Hand-on course: ultrasound
Prof P.E. De Jong Division of Nephrology University Hospital of Groningen Groningen, The Netherlands		Prof J. Radermacher Department of Nephrology Klinikum Minden Minden, Germany


	Diagnostic problems in diabetic nephropathy: histological findings and non-immunoreactive albumin		Insulin resistance and its role on initiation and progression of diabetic nephropathy
Prof P. Fioretto Department of Medical and Surgical Sciences University of Padova Padova, Italy		Prof M. Laville Service de Nephrology - Universitè Claude Bernard Hopital E. Herriot Lyon, France

	Diabetic nephropathy: epidemiology and prevention
Prof M. Ravid Sakler Faculty of Medicine University of Tel Aviv Tel Aviv, Italy

Transplantation

Clinical Nephrology

Prof J.M. Campistol
Renal Transplant Unit
Hospital Clinic
University of Barcelona
Barcelona, Spain

Prof J.P. Grünfeld
Université Paris-Descartes
Hôpital Necker
Paris, France


	New perspectives for the treatment of immune-mediated diseases from an old drug: thalidomide and its second generation		Treatment of idiopathic nephrotic syndrome with immunophillin modulation
Prof R. Coppo Director of the Nephrology, Dialysis and Transplantation Department Regina Margherita Hospital Turin, Italy		Prof A. Meyrier Nephrology Service INSERM U430 University Hospitals Broussais & HEGP Paris, France

	Complement and complement inhibitors
Prof M. Daha Dept of Nephrology Leiden University Medical Center Leiden, The Netherlands

EPO and organ protection

Prof D. Fliser
Dept. of Nephrology
Hannover Medical School
Hannover, Germany


	Biochemical indicators of endothelial dysfunction in CKD and hypertension		Obesity and renal disease
Dr F. Mallamaci Nephrology, Dialysis, Transplantation and Hypertension Unit, OO.RR and CNR Istituto di Biomedicina, Laboratorio di Epidemiologia Clinica e Fisiopatologia delle Malattie Renali e dell'Ipertensione Reggio Calabria, Italy		Prof G. Wolf Department of Medicine University of Jena Jena, Germany


	Pathogenesis of thrombotic microangiopathies		Treatment of thrombotic microangiopathy
Prof G. Remuzzi Mario Negri Bergamo Institute Bergamo, Italy		Prof. C. Loirat Service de Nephrologie Pediatrique Hopital Robert Debre Paris, France

	Renal changes in normal and pathologic pregnancy		Pregnancy in CKD and after kidney transplantation
Dr. P. Ruggenenti Renal Research Department Mario Negri Institute Bergamo, Italy		Dr. S. Goral Division of Renal, Electrolytes and Hypertension University of Pennsylvania School of Medicine Philadelphia, PA, USA

Tubular sodium handling and hypertension.

Renovascular hypertension and atherosclerotic nephropathy. How to diagnose and treat

Prof M. Burnier
Head Div. of Nephrology and Hypertension Consultation
CHUV
Lausanne, Switzerland

Dr J. Scoble
Renal Unit
Guy’s Hospital
London, United Kingdom


	Indicators, clinical performance measures and beyond: what Renal Registries can do to improve clinical practice in dialysis clinics. Some evidence from the UK Renal Registry		The impact of guidelines on clinical practice
Dr E.J. Will Renal Service St. James's University Hospital Leeds, United Kingdom		Prof N. Levin Renal Research Institute Albert Einstein College of Medicine New York, NY, USA

	Global guidelines in nephrology: perspectives and barriers		EBPG: how do they compare to world-wide guidelines?
Prof G. Eknoyan Renal Section, Department of Medicine Baylor College of Medicine Houston, TX, USA		Prof R. Vanholder Nephrology Section, Department of Internal Medicine University Hospital Ghent , Belgium


	General overview: bone remodelling and chronic renal failure		Low bone turnover: should we stimulate bone turnover in dialysis patients
Prof G. Coen Ospedale Israelitico Nephrology and Hypertension Unit Rome, Italy		Prof T.B. Drueke Inserm U507 and Service de Nephrologie Hôpital Necker Paris, France

	Individualized renal replacement therapy in ARF		Effect of biofeedback systems for monitoring haemodialysis treatments
Prof N. Lameire Chief Renal Division University of Ghent Ghent, Belgium		Prof T. Petitclerc Department of Nephrology Pitié-Salpétrière Hospital Paris, France


	Dialysis		Glomerular, tubular and interstitial diseases: advances in basic and clinical science
Dr F. Locatelli Dipartimento Nefro-Urologico Ospedale "A. Manzoni" Lecco, Italy		Prof. D. Schlöndorff Direktor Medizinische Poliklinik - Innenstadt Klinikum der Universität München Munich, Germany


	The association between CKD and cardiovascular disease: cause or consequence?		Endothelial dysfunction and early renal dysfunction
Dr P. Parfrey Memorial University of Newfoundland St. John's Newfoundland, Canada		Prof C. Zoccali Unità di Nefrologia, Dialisi, Trapianto e Ipertensione OO.RR and CNR Istituto di Biomedicina Laboratorio di Epidemiologia Clinica e Fisiopatologia delle malattie Renali e dell'Ipertensione Reggio Calabria, Italy

	Differential indication for ace-inhibitors, at1-blockers and their combination		Aldosterone and kidney disease: what are the links?
Prof J. Mann Dept. of Nephrology and Hypertension Schwabing General Hospital LMU Munich, Germany		Prof P.-Y. Martin Division of Nephrology Department of Medicine Geneva University Hospital Geneva, Switzerland


	Global epidemiology and public health: the years of epidemiologic transition		Epidemiology of cardiovascular risk in ESRD on trial. From the direct to the reverse. What have we learnt from observational studies?
Prof R. LaPorte Director, Disease Monitoring and Telecommunications WHO Collaborating Centre Professor of Epidemiology Pittsburgh, PA, USA		Dr R.N. Foley Nephrology Analytical Services, Chronic Disease Research Group Minneapolis Medical Research Foundation and University of Minnesota Minneapolis, MN, USA


	Anaemia outcomes and practice pattern challenges		Vascular access practice patterns and outcomes across DOPPS countries
Prof B. Canaud Service de Nephrologie Hopital Lapeyronie Montpellier, France		Dr H. Rayner Department of Renal Medicine Birmingham Heartland Hospital Birmingham, United Kingdom